Printer Friendly

... With particles called bubbicles.

Two researhers at the University of Rochester (N.Y.) have applied for a patent on their "bubbicles" -- long-lasting, air-packed particles that enhance the utility of ultrasound for imaging liver tumors. This contrast agent consists of a synthetic, iodine-packed chemical called iodipamide ethyl ester, says physical chemist and inventor Michael R. Violante.

The porous bubbicle, 1 micrometer in diameter, resembles a hard, air-filled sponge. It holds its air much better than albumin-coated microspheres, according to Violante and co-inventor Kevin J. Parker.

As a result, the bubbicles--which are one-sixth the size of red blood cells -- stay in the blood until liver cells filter them out. Once in the liver, they "produce a tremendous increase in brightness," says Parker. Cancer cells in the liver do not absorb the bubbicles, so tumors appear much darker than surrounding tissue in ultrasound images.

Medisperse Limited Partnership in Rochester plans to develop and test the bubbicles for clinical applications, says Violante, the company's managing director. He thinks bubbicles may also prove useful for imaging blood flow in the body's deep-seated vessels.
COPYRIGHT 1991 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:particles to enhance the ultrasound imaging of liver tumors
Publication:Science News
Date:Sep 28, 1991
Words:174
Previous Article:Make medical imaging effervesce....
Next Article:Fred McLaren: subs, science and subscribers.
Topics:


Related Articles
Putting the freeze on liver tumors.
Clues to a new class of liver carcinogens.
Sonochemistry: the ultrasound and the fury.
Vibration imaging: sounding out tumors.
Pummeling tumors with localized therapies.
Ultrasound prevents blood loss in surgery.
The role of ultrasonography in the management of tumors of the neck.
Beyond Imaging.
POTENTIAL ANTI-CANCER AGENT INVESTIGATED AT NIST.
Ultrasound boosts drug delivery to tumors. (Biomedicine: From Chicago, at the 87th annual meeting of the Radiological Society of North America).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters